A cost-effective analysis of adjuvant therapies for the treatment of stage I endometrial adenocarcinoma
Jason A. Lachance(University of Virginia), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), George J. Stukenborg(University of Virginia Health System), Bernard F. Schneider(University of Virginia Health System), Laurel W. Rice(University of Virginia)
Cited by 25
Related Papers
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
|Nature Medicine|2023|508
Gene Expression Profiles of BRCA1-Linked, BRCA2-Linked, and Sporadic Ovarian Cancers
|JNCI Journal of the National Cancer Institute|2002|285
Normal and Cancerous Tissues Release Extrachromosomal Circular DNA (eccDNA) into the Circulation
|Molecular Cancer Research|2017|285